When Weight Gain Is Not Menopause: Labs Worth Discussing at an HRT Visit

Menopause is a convenient explanation, and it absorbs a lot of symptoms that belong to something else. Fatigue, weight gain, cold intolerance, brain fog, and hair thinning are all on the menopause list — and they are also on the hypothyroidism list, the iron deficiency list, and the insulin resistance list.

This article is not about whether hormone therapy changes your weight; that question is covered in HRT and weight: gain, loss, or no change?. This is about the cases where the answer is that it was never really about menopause.

The pattern that should raise a question

Some weight change genuinely fits the menopause transition: a gradual gain of a few pounds a year, a redistribution toward the waist, and a slow softening of the same body.

These patterns fit less well:

• Rapid gain — several pounds over a few months without a corresponding change in eating or activity
• Weight gain plus feeling cold, constipated, hoarse, or unusually slow
• Weight gain plus a genuinely inadequate response to consistent, well-executed diet and training over three months or more
• Unintentional weight loss. This is the one that gets celebrated and should not be. Unexplained loss warrants evaluation, not congratulation.
• Fatigue out of proportion to sleep quality, particularly with heavy periods
• Darkened velvety skin in the neck or armpit folds, or a rash of new skin tags — both are visible signs of insulin resistance

Thyroid: TSH and free T4

TSH is the pituitary's signal telling the thyroid to work harder. It rises when the thyroid is underperforming and falls when it is overperforming. Because the pituitary is exquisitely sensitive, TSH moves before the thyroid hormones themselves do, which is why it is the first-line test.

Free T4 is the thyroid's main output. Read together with TSH, it separates the possibilities:

• High TSH with low free T4 — overt hypothyroidism. Treated with levothyroxine.
• High TSH with normal free T4 — subclinical hypothyroidism. Common, and frequently over-treated. Whether to treat depends on how high the TSH is, whether you have symptoms, and whether thyroid antibodies are present. Mild elevations often normalize on a repeat test.
• Low TSH — points toward an overactive thyroid, which typically causes weight loss, heat intolerance, palpitations, and anxiety rather than weight gain.

Two things to be honest about. First, reference ranges are assay-specific — your result has to be read against the range printed on your own lab report, and a number quoted from an article is meaningless. Second, hypothyroidism is a real cause of weight gain but a modest one. Correcting it typically returns a few pounds, largely retained fluid, not twenty. Levothyroxine is a thyroid treatment, not a weight loss drug, and using it as one causes bone loss and atrial fibrillation.

TPO antibodies are worth adding when TSH is borderline or there is a family history — a positive result means Hashimoto's thyroiditis and predicts progression, which changes how closely you get monitored.

Tests that sound useful and are not

• Free T3 does not diagnose hypothyroidism and does not explain symptoms in someone with a normal TSH and free T4.
• Reverse T3 has no established clinical use. It is a marker of illness and calorie restriction, not a diagnosis.
• "Adrenal fatigue" is not a recognized medical diagnosis, and salivary cortisol panels sold to investigate it are not a valid test for anything.

The interaction that matters if you are already on levothyroxine

Oral estrogen raises thyroxine-binding globulin, which increases the amount of levothyroxine you need. If you are treated for hypothyroidism and start oral hormone therapy, your TSH should be rechecked roughly 6 to 8 weeks later and the dose is often adjusted upward. Transdermal estrogen — patch or gel — bypasses first-pass liver metabolism and does not do this.

Mention biotin if you take it. High-dose biotin, common in hair and nail supplements, interferes with many thyroid immunoassays and can produce results that mimic hyperthyroidism. The FDA has issued a safety communication about this. Stopping it for a few days before the draw resolves it.

Blood sugar and insulin

HbA1c reflects average glucose over roughly the previous three months. It requires no fasting, which makes it the most practical screening test. The American Diabetes Association's thresholds:

• 5.7 to 6.4 percent — prediabetes
• 6.5 percent or above — diabetes, on two occasions or with a confirmatory test

It is less reliable if you have anemia, a hemoglobin variant, chronic kidney disease, or recent blood loss — and heavy menstrual bleeding in perimenopause is enough to distort it. That is a genuine limitation, not a technicality.

Fasting plasma glucose is a single-point measurement. 100 to 125 mg/dL is prediabetes; 126 mg/dL or above on two occasions is diabetes. It catches some people whose HbA1c is misleading, and vice versa.

The USPSTF recommends screening for prediabetes and type 2 diabetes in adults aged 35 to 70 who are overweight or have obesity. Most women asking these questions in midlife already qualify.

Fasting insulin and HOMA-IR deserve a plain answer, because they are heavily marketed. Insulin does rise before glucose does, so conceptually the test is measuring something real. But insulin assays are not standardized between laboratories, there is no validated diagnostic cut-off, and no professional body recommends it for routine clinical use. A result will not change what you are advised to do — the response to insulin resistance is the same regardless of the number. It is not wrong to check it. It is wrong to build a treatment plan on it.

If you have a history of irregular cycles and long-standing weight difficulty, insulin resistance may sit inside a larger picture — see polycystic ovary syndrome: diagnosis, phenotypes, and treatment.

Lipids

Cholesterol shifts adversely across the menopause transition, and it does so somewhat independently of weight. A fasting or non-fasting lipid panel gives total cholesterol, LDL, HDL, and triglycerides.

The pattern that travels with insulin resistance is high triglycerides with low HDL. When that combination appears alongside central weight gain and a raised HbA1c, the picture is metabolic rather than menopausal — and the cardiovascular risk it represents is more consequential than the weight itself.

This is worth checking at midlife regardless of symptoms, as part of routine check-ups.

Ferritin and iron

This is the test most often left out, and in a gynecology practice it should not be.

Ferritin measures iron stores. Fatigue, hair shedding, exercise intolerance, and poor recovery from training are all caused by iron deficiency before anemia develops — meaning a normal hemoglobin does not rule it out. Any woman with heavy periods, and any woman who has recently become vegetarian or vegan, deserves a ferritin rather than a full blood count alone.

Ferritin is also an acute-phase reactant, so it rises with inflammation and can look falsely reassuring during an infection or a flare of inflammatory disease.

If your periods are heavy, that is treatable in its own right — see heavy periods in your 30s and 40s.

Also consider vitamin D, which is frequently low in Chicago winters and contributes to fatigue and muscle aches that get attributed to menopause.

What is not worth testing

Estradiol and FSH do not diagnose perimenopause in a woman over 45 with typical symptoms, and they do not guide hormone therapy dosing outside specific situations. Levels swing so widely during the transition that a single measurement is uninformative and sometimes actively misleading. Dosing is titrated to symptoms. This is covered further in signs you may be a candidate for HRT.

Red flags: investigate, do not adjust the dose

Some findings mean the conversation stops being about weight.

• Any vaginal bleeding after menopause. This requires evaluation before anything else is changed. It is not a hormone therapy dosing question.
• Unintentional weight loss of more than about 5 percent of body weight
• A new neck lump or swelling, difficulty swallowing, or persistent hoarseness
• Marked thirst and frequent urination, particularly with blurred vision — this needs same-day glucose testing
• Palpitations, tremor, or heat intolerance with weight loss
• Rapidly progressive swelling of the face or legs
• Chest pain, fainting, or new severe shortness of breath — emergency care

How to make the visit useful

1. Bring a timeline. When the weight changed, and what else changed in the same window — sleep, periods, bowel habits, medications, temperature tolerance.
2. Bring the full list of supplements, biotin included.
3. Ask which result best explains your symptoms, and which do not fit.
4. Ask when to recheck. Most changes need 6 to 12 weeks before a repeat test means anything.
5. Change one variable at a time. Starting hormone therapy, adjusting levothyroxine, and overhauling your diet in the same month makes the result uninterpretable.

Talk to us

• HRT and weight: gain, loss, or no change?
• Eating for fat loss on HRT: protein, fiber, and timing
• Strength training in midlife: a weekly plan
• Menopause management
• Routine check-ups and preventive care
• Book an appointment online

Medical disclaimer

This article is general health information, not medical advice for any individual. Laboratory reference ranges differ between laboratories and results must be interpreted alongside your symptoms and history by a clinician who knows you. Bleeding after menopause, unintentional weight loss, or marked thirst with frequent urination should be evaluated promptly rather than waiting for a routine visit.